» Articles » PMID: 29341867

Genetic and Microbiome Influence on Lipid Metabolism and Dyslipidemia

Overview
Date 2018 Jan 18
PMID 29341867
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

Disruption in the metabolism of lipids is broadly classified under dyslipidemia and relates to the concentration of lipids in the blood. Dyslipidemia is a predictor of cardio-metabolic disease including obesity. Traditionally, the large interindividual variation has been related to genetic factors and diet. Genome-wide association studies have identified over 150 loci related to abnormal lipid levels, explaining ~40% of the total variation. Part of the unexplained variance has been attributed to environmental factors including diet, but the extent of the dietary contribution remains unquantified. Furthermore, other factors are likely to influence lipid metabolism including the gut microbiome, which plays an important role in the digestion of different dietary components including fats and polysaccharides. Here we describe the contributing role of host genetics and the gut microbiome to dyslipidemia and discuss the potential therapeutic implications of advances in understanding the gut microbiome to the treatment of dyslipidemia.

Citing Articles

Chylomicron Characteristics Are Associated With Microsomal Triglyceride Transfer Protein in an Animal Model of Diet-Induced Dysbiosis.

Olano C, Farina G, Wiszniewski M, Medel J, Morales C, Friedman S J Lipid Atheroscler. 2025; 14(1):106-119.

PMID: 39911957 PMC: 11791422. DOI: 10.12997/jla.2025.14.1.106.


Altered gut microbiome and serum metabolome profiles associated with essential tremor.

Yan Z, Zheng Z, Cao L, Zhu Z, Zhou C, Sun Q Metab Brain Dis. 2025; 40(2):118.

PMID: 39903340 DOI: 10.1007/s11011-025-01549-2.


Interplays of Dietary Fat with BMI and rs324420 on HDL-C in Gender-Dependent Manner in Adolescents.

Shen Y, Qiu L, Cai J, Guo Q, Chen X, Su G Food Sci Nutr. 2024; 12(11):9287-9294.

PMID: 39619958 PMC: 11606812. DOI: 10.1002/fsn3.4497.


Primary Prevention Strategy for Non-Communicable Diseases (NCDs) and Their Risk Factors: The Role of Intestinal Microbiota.

Lopez-Tenorio I, Aguilar-Villegas O, Espinoza-Palacios Y, Segura-Real L, Pena-Aparicio B, Amedei A Biomedicines. 2024; 12(11).

PMID: 39595097 PMC: 11591598. DOI: 10.3390/biomedicines12112529.


Helicobacter pylori infection increases the risk of dyslipidemia in Chinese diabetic Population: a retrospective cross-sectional study.

Yang C, You N, Chen Y, Zhang J BMC Infect Dis. 2024; 24(1):730.

PMID: 39054452 PMC: 11270938. DOI: 10.1186/s12879-024-09597-2.


References
1.
Wu G, Chen J, Hoffmann C, Bittinger K, Chen Y, Keilbaugh S . Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334(6052):105-8. PMC: 3368382. DOI: 10.1126/science.1208344. View

2.
Furusawa Y, Obata Y, Fukuda S, Endo T, Nakato G, Takahashi D . Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504(7480):446-50. DOI: 10.1038/nature12721. View

3.
Kathiresan S, Melander O, Guiducci C, Surti A, Burtt N, Rieder M . Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 2008; 40(2):189-97. PMC: 2682493. DOI: 10.1038/ng.75. View

4.
Noriega B, Sanchez-Gonzalez M, Salyakina D, Coffman J . Understanding the Impact of Omega-3 Rich Diet on the Gut Microbiota. Case Rep Med. 2016; 2016:3089303. PMC: 4808672. DOI: 10.1155/2016/3089303. View

5.
Canfora E, Jocken J, Blaak E . Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol. 2015; 11(10):577-91. DOI: 10.1038/nrendo.2015.128. View